The case for including proteomics in routine diagnostic practice for rare disease

Area of Science:

• Genomics and Proteomics
• Rare Disease Diagnostics
• Personalized Medicine

Background:

• Undiagnosed rare diseases present a significant barrier to personalized therapy.
• Current diagnostic workflows often fail to identify the underlying genetic causes.
• Proteomics, the study of proteins, remains underutilized in clinical diagnostics.

Discussion:

• Integrating proteomics into rare disease diagnostics can overcome limitations of genetic testing alone.
• This approach aids in identifying novel biomarkers and disease mechanisms.
• Accelerating diagnosis through advanced techniques like proteomics is crucial.

Key Insights:

• A confirmed genetic diagnosis is essential for accessing tailored treatments for rare diseases.
• Proteomics offers a powerful, yet underused, tool for diagnostic advancement.
• Shortening the diagnostic odyssey is a primary goal for improving patient outcomes.

Outlook:

• Future diagnostic strategies should incorporate multi-omics approaches, including proteomics.
• Wider adoption of proteomics in clinical settings will expand therapeutic possibilities.
• Continued research is needed to fully leverage proteomics for rare disease management.